NCT06542120

Brief Summary

The purpose of this research is to develop a body voice artificial intelligence (AI) recognition device, also referred to as an AI-assisted body sound identification device, by utilizing a deep learning-based novel AI algorithm in conjunction with a big body voice model. It could identify normal and abnormal heart, breath, and bowel sounds, and to provide early screening and auxiliary diagnosis of congenital heart disease (CHD), respiratory infections, diarrhea and other common multi-occurring diseases.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

5 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 7, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

August 21, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

August 7, 2024

Status Verified

April 1, 2024

Enrollment Period

11 months

First QC Date

August 4, 2024

Last Update Submit

August 6, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Sensitivity

    Sensitivity in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation

    1 month

  • Specificity

    Specificity in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation

    1 month

  • AUC

    AUC in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation

    1 month

Study Arms (1)

0 ~ 18 years old children

Age range: 0 to 18 years old, with no gender restriction. Children who have been diagnosed with congenital heart disease (CHD) or confirmed to be free of CHD through echocardiographic examinations. Children who have been diagnosed with bronchopneumonia or confirmed to be free of bronchopneumonia through chest imaging examinations. Children who have been diagnosed with abdominal diseases or confirmed to be free of abdominal diseases through abdominal imaging examinations.

Diagnostic Test: Heart Auscultation and EchocardiographyDiagnostic Test: Chest Auscultation and Chest imaging examinationsDiagnostic Test: Abdominal Auscultation and Abdominal imaging examinations

Interventions

Heart auscultation will be done by pediatrician and echocardiography by echocardiologist

0 ~ 18 years old children

Chest auscultation will be done by pediatrician and chest imaging examinations by radiologist

0 ~ 18 years old children

Abdominal auscultation will be done by pediatrician and chest imaging examinations by radiologist

0 ~ 18 years old children

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

1. Children (0-18 years old) with congenital heart disease confirmed by cardiac ultrasound and children without congenital heart disease confirmed by cardiac ultrasound. 2. Children (0-18 years old) with bronchopneumonia confirmed by chest imaging examination and children without bronchopneumonia confirmed by imaging. 3. Children (0-18 years old) with abdominal imaging confirmed abdominal disease and children diagnosed without abdominal disease by imaging.

You may qualify if:

  • Age 0\~18 years old, gender is not limited
  • Children who have been diagnosed with congenital heart disease by cardiac ultrasound or who do not have congenital heart disease
  • Children diagnosed with bronchopneumonia or without bronchopneumonia
  • Children who are clinically diagnosed with intestinal diseases or who do not suffer from intestinal diseases
  • Informed consent

You may not qualify if:

  • ≥ 18 years old
  • Children who are unable to undergo cardiac ultrasound, chest imaging or other related examinations
  • Subjects who are unable to obtain informed consent, or who are unwilling to cooperate with the provision of diagnosis and treatment related data for further analysis and research as required by the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, 430016, China

Location

Human Children's Hospital

Changsha, Hunan, 410007, China

Location

Xinhua Hospital,Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200092, China

Location

Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine

Shanghai, Shanghai Municipality, 200127, China

Location

Kunming children's Hospital

Kunming, Yunnan, 650028, China

Location

MeSH Terms

Conditions

Heart Defects, CongenitalBronchopneumonia

Interventions

Heart AuscultationEchocardiography

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPneumoniaRespiratory Tract InfectionsInfectionsBronchial DiseasesRespiratory Tract DiseasesLung Diseases

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisAuscultationPhysical ExaminationCardiac Imaging TechniquesDiagnostic ImagingUltrasonography

Study Officials

  • Xin Sun, MD

    Xinhua Hospital, Shanghai J iao Tong University School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2024

First Posted

August 7, 2024

Study Start

August 21, 2024

Primary Completion

July 31, 2025

Study Completion

December 30, 2025

Last Updated

August 7, 2024

Record last verified: 2024-04

Locations